Search Results - "Bertelli, G"

GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial by Leonard, R.C.F., Adamson, D.J.A., Bertelli, G., Mansi, J., Yellowlees, A., Dunlop, J., Thomas, G.A., Coleman, R.E., Anderson, R.A.

“…Chemotherapy-induced premature ovarian insufficiency (POI) impacts fertility and other aspects of women’s health. The OPTION trial tested whether…”
Get full text

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) by Coleman, R.E., Collinson, M., Gregory, W., Marshall, H., Bell, R., Dodwell, D., Keane, M., Gil, M., Barrett-Lee, P., Ritchie, D., Bowman, A., Liversedge, V., De Boer, R.H., Passos-Coelho, J.L., O'Reilly, S., Bertelli, G., Joffe, J., Brown, J.E., Wilson, C., Tercero, J.C., Jean-Mairet, J., Gomis, R., Cameron, D.

“…Adjuvant bisphosphonates improve disease outcomes in postmenopausal early breast cancer (EBC) but the long-term effects are poorly described. The AZURE trial…”
Get full text

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial by Coombes, RC, Prof, Kilburn, LS, MSc, Snowdon, CF, MSc, Paridaens, R, Prof, Coleman, RE, Prof, Jones, SE, MD, Jassem, J, Prof, Van de Velde, CJH, Prof, Delozier, T, MD, Alvarez, I, MD, Del Mastro, L, MD, Ortmann, O, Prof, Diedrich, K, Prof, Coates, AS, Prof, Bajetta, E, Prof, Holmberg, SB, MD, Dodwell, D, MD, Mickiewicz, E, MD, Andersen, J, DMSc, Lønning, PE, Prof, Cocconi, G, Prof, Forbes, J, Prof, Castiglione, M, Prof, Stuart, N, MD, Stewart, A, MD, Fallowfield, LJ, Prof, Bertelli, G, MD, Hall, E, PhD, Bogle, RG, MD, Carpentieri, M, PhD, Colajori, E, MD, Subar, M, MD, Ireland, E, MSc, Bliss, JM, Prof

“…Summary Background Early improvements in disease-free survival have been noted when an aromatase inhibitor is given either instead of or sequentially after…”
Get full text

Right-side fixation of the sigmoid colon causing internal herniation with closed-loop obstruction of both small and large bowel: a case report and review of the literature by Bertelli, G, Patauner, S, Gorgatti, T, Frena, A

“…Abstract Background Right-side fixation of the sigmoid colon is a rare anatomical variant associated with intestinal malrotation (Choi et al . in J Korean Surg…”
Get full text

A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK by Holt, S, Bertelli, G, Humphreys, I, Valentine, W, Durrani, S, Pudney, D, Rolles, M, Moe, M, Khawaja, S, Sharaiha, Y, Brinkworth, E, Whelan, S, Jones, S, Bennett, H, Phillips, C J

“…Background: Tumour gene expression analysis is useful in predicting adjuvant chemotherapy benefit in early breast cancer patients. This study aims to examine…”
Get full text

OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer by Frangou, E., Bertelli, G., Love, S., Mackean, M.J., Glasspool, R.M., Fotopoulou, C., Cook, A., Nicum, S., Lord, R., Ferguson, M., Roux, R.L., Martinez, M., Butcher, C., Hulbert-Williams, N., Howells, L., Blagden, S.P.

“…Fear of disease progression (FOP) is a rational concern for women with Ovarian Cancer (OC) and depression is also common. To date there have been no randomized…”
Get full text

Management of advanced ovarian cancer in South West Wales − a comparison between primary debulking surgery and primary chemotherapy treatment strategies in an unselected, consecutive patient cohort by Drews, F, Bertelli, G, Lutchman-Singh, K

“…Highlights • Study is first report of outcomes for advanced ovarian cancer in Wales, and in UK since publication of recent RCT’s. • Study corroborates recent…”
Get full text

MRONJ risk reduction pathway - 360 degree survey by Muthukrishnan, A., Al-Ismail, S., Bertelli, G., Browne, P.

“…Key Points Preventive dental screening reduces the incidence of MRONJ/BRONJ. A cross-service cross-healthcare boundary preventive pathway was developed…”
Get full text

Clinical outcomes according to age and comorbidities in the OSCAR UK observational study of front-line bevacizumab (BEV)-containing therapy for advanced ovarian cancer (aOC) by Hall, M., Bertelli, G., Li, L., Green, C., Chan, S., Yeoh, C.C., Hasan, J., Ograbek, A., Perren, T.J.

Get full text

Sequencing of aromatase inhibitors by Bertelli, G

“…Since the development of the third-generation aromatase inhibitors (AIs), anastrozole, letrozole and exemestane, these agents have been the subject of…”
Get full text

OVPSYCH2: A randomised study of psychological support versus standard of care following chemotherapy for ovarian cancer by Blagden, S., Bertelli, G., Frangou, E., Butcher, C., Love, S., Mackean, M., Glasspool, R.M., Cook, A., Nicum, S., Lord, R., Ferguson, M., Roux, R.L., Martinez, M., Black, S., James, A., Palmer, H., Hughes, S., Marriott, C., Howells, L.

Get full text

Reply to the letter to the editor ‘Measured and estimated glomerular filtration rate for carboplatin dose calculation’ by Cathomas et al by Bertelli, G., Quinton, A.E., Lewis, P.D., Ali, P., Morgan, C.

Get full text

88. Validity of Oncotype Dx recurrence score in predicting recurrence in hormone receptor positive and node negative early breast cancer patients by Munir, A, Udyashankar, S, Thomas, D, Dazeley, G, Huws, A, Bertelli, G, Shariah, Y, Khawaja, S, Holt, S

Get full text

A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma by Quinton, A., Lewis, P., Ali, P., Morgan, C., Bertelli, G.

“…Dose calculation of adjuvant carboplatin chemotherapy for stage I testicular seminoma, based on area under the concentration curve (AUC), incorporates the…”
Get full text

The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer by Numico, G., Anfossi, M., Bertelli, G., Russi, E., Cento, G., Silvestris, N., Granetto, C., Di Costanzo, G., Occelli, M., Fea, E., Garrone, O., Gasco, M., Colantonio, I., Merlano, M.

“…Surveys carried out in Mediterranean countries demonstrated very low rates of awareness of both diagnosis and prognosis among cancer patients. In our…”
Get full text

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen by Bertelli, G., Hall, E., Ireland, E., Snowdon, C.F., Jassem, J., Drosik, K., Karnicka-Mlodkowska, H., Coombes, R.C., Bliss, J.M.

“…The antiestrogen tamoxifen may have partial estrogen-like effects on the postmenopausal uterus. Aromatase inhibitors (AIs) are increasingly used after initial…”
Get full text

Breast angiosarcoma following lumpectomy and radiotherapy for breast cancer: a case with short latent period and false negative result on biopsies by Moe, M, Bertelli, G

Get full text

Spectroscopic survey of the Galaxy with Gaia- I. Design and performance of the Radial Velocity Spectrometer by Katz, D., Munari, U., Cropper, M., Zwitter, T., Thévenin, F., David, M., Viala, Y., Crifo, F., Gomboc, A., Royer, F., Arenou, F., Marrese, P., Sordo, R., Wilkinson, M., Vallenari, A., Turon, C., Helmi, A., Bono, G., Perryman, M., Gómez, A., Tomasella, L., Boschi, F., Morin, D., Haywood, M., Soubiran, C., Castelli, F., Bijaoui, A., Bertelli, G., Prsa, A., Mignot, S., Sellier, A., Baylac, M.-O., Lebreton, Y., Jauregi, U., Siviero, A., Bingham, R., Chemla, F., Coker, J., Dibbens, T., Hancock, B., Holland, A., Horville, D., Huet, J.-M., Laporte, P., Melse, T., Sayède, F., Stevenson, T.-J., Vola, P., Walton, D., Winter, B.

“…ABSTRACT The definition and optimization studies for the Gaia satellite spectrograph, the ‘radial velocity spectrometer’ (RVS), converged in late 2002 with the…”
Get full text

Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study by Bertelli, G., Venturini, M., Del Mastro, L., Bergaglio, M., Sismondi, P., Biglia, N., Venturini, S., Porcile, G., Pronzato, P., Costantini, M., Rosso, R.

“…Background Hot flashes are frequent in postmenopausal breast cancer patients, especially when treated with tamoxifen. Estrogen replacement therapy is the most…”
Get full text

Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer by Novarino, A., Chiappino, I., Bertelli, G. F., Heouaine, A., Ritorto, G., Addeo, A., Bellone, G., Merlano, M., Bertetto, O.

“…Background: The aim of this study was to determine the activity of the combination of cisplatin, gemcitabine and 5-fluorouracil (5-FU) as therapy for…”
Get full text